Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice,
the treatment of aortic stenosis has changed dramatically. In the past, medical therapy with …

Objective The aim of this study was to conduct a weighted meta-analysis to determine the
rates of acute (≤ 30 days) major outcomes after (TAVR) with second-generation devices …

Background—Off-label use of transcatheter aortic and pulmonary valve prostheses for
tricuspid valve-in-valve implantation (TVIV) within dysfunctional surgical tricuspid valve (TV) …

Background: Transcatheter aortic and pulmonary valves have been used to treat stenosis or
regurgitation after prior surgical tricuspid valve (TV) replacement or repair. Little is known …

Aortic stenosis is the most common valvular heart disease in the developed world. About 7%
of the population over age 65 years suffers from degenerative aortic stenosis. The prognosis …

Background Transcatheter aortic valve implantation (TAVI) is increasingly applied for aortic
stenosis in elderly patients with impaired mobility and reduced quality of life. These patients …

Background A minimalist approach for transcatheter aortic valve replacement (MA-TAVR)
utilizing transfemoral access under conscious sedation and transthoracic echocardiography …

Objectives In this study, we compare procedural results of our first Evolut R (Medtronic,
Minneapolis, MN, USA) implantations with the last CoreValve implantations. Main endpoints …

Quadricuspid aortic valve (QAV) is a congenital heart anomaly in which the aortic valve has
four cusps of various size possibilities, as opposed to the three symmetrical cusps generally …

Background Transcatheter aortic valve replacement (TAVR) is an effective alternative to
surgical aortic valve replacement in patients at high surgical risk. However, there is little …